MedTrace Logo

The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.

NCT02247245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-01-02

Study results available
· View outcomes & findings →

Summary

To examine the effects of heart rate reduction on exercise capacity in control subjects and patients with chronic heart failure.

Conditions

Interventions

DRUG

Ivabradine

Ivabradine 7.5mg

OTHER

Atrial fibrillation

Pacemaker base rate alteration

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Klaus K Witte, FRCP MD · University of Leeds

  • Haqeel A Jamil, MbChB MRCP · University of Leeds

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247245 on ClinicalTrials.gov